JamesMMarkertMD

Brain & Spinal Tumor

Professor of Neurological Surgery, University Alabama

Dr. Markert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

PubMed

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.
Colin H Quinn, Janet R Julson, Hooper R Markert, Nazia Nazam, Swatika Butey
Cancer Immunology, Immunotherapy. 2024-09-05
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent.
Stacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang, Sam E Gary, Abbey Rocco
Molecular Cancer Therapeutics. 2024-09-04
6 citations
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma.
Justin T Low, Michael C Brown, Zachary J Reitman, Joshua D Bernstock, James M Markert
The Journal of Clinical Investigation. 2024-01-16

Journal Articles

Original Article Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of HSV-1 G207 in Pediatric Malignant Supratentorial Brain Tumors
Asim K Bag, G Yancey Gillespie, Gregory K Friedman, Zachary Wright, James M Markert, James M Johnston, ScienceDirect

Lectures

63rd Southern Neurosurgical Society Annual Meeting Presidential Address
Southern Neurosurgical Society, Amelia Island, Florida - 3/28/2012

Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018
Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care UnitJanuary 2018

UAB Neurosurgery Launches STEM Initiative in Elementary SchoolsJanuary 10th, 2023
Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
Join now to see all

Lessons From The OR: Using Clinical Biologic Correlates To Inform HSV TrialNational Cancer Institute2009–2011
CT 2001 A Staged Phase I Study Of The Treatment Of Malignant Glioma With G207,National Center For Research Resources2006–2007
Genetically Engineered HSV 1 In Malignant GliomaNational Center For Research Resources1999–2002
Engineered Herpes Simplex Virus For Treatment Of GliomasNational Institute Of Neurological Disorders And Stroke1997–2001